MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,818.93
+0.58%
NASDAQ 100
$31,224.47
+0.48%
DOW JONES
$51,521.00
+0.49%
NASDAQ Composite
$27,599.79
+0.45%
RUSSELL 2000
$2,813.40
-0.72%
CBOE VIX
$15.01
-3.29%
Sector Heatmap
Technology+0.53%
Financials+0.24%
Healthcare-0.17%
Consumer Cycl+1.20%
Consumer Staples+0.90%
Energy+0.47%
Industrials+0.87%
Materials+0.46%
Real Estate+1.06%
Utilities+2.98%
Comm Services+0.04%
OCUL — Ocular Therapeutix, Inc.
NasdaqOcular Therapeutix, Inc.
$7.34
+0.09(+1.24%)
- O
- 7.30
- H
- 7.57
- L
- 7.13
- V
- 2.79M
⏱️ End-of-day dataAs of Oct 6, 2026
Chart
About OCUL
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateJul 25, 2014
Employees325
Stock ExchangeNasdaq
Ticker SymbolOCUL
Websitehttps://www.ocutx.com
Key Financial Statistics
| Market Cap | $1.53B |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $6.23 - $16.44 |
| 52-Week Avg Volume | 3.76M |
| VWAP | $7.35 |
| Transactions | 26,168 |
| Total Recorded Bars | 3,068 days |